SCHEMBL9340546

SCHEMBL9340546

O=Cc1cc(Cl)c(F)c(C(F)(F)F)c1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.42
ALDH1A1 P00352 1/20 0.41
NPFFR1 Q9GZQ6 2/20 0.34
NPFFR2 Q9Y5X5 2/20 0.34
ALDH1A3 P47895 3/20 0.33
KDR P35968 1/20 0.32
HSD17B10 Q99714 1/20 0.31
GRIA1 P42261 1/20 0.31
GRIA2 P42262 1/20 0.31
GRIA3 P42263 1/20 0.31
GRIA4 P48058 1/20 0.31
NR3C1 P04150 1/20 0.30
PGR P06401 1/20 0.30
NR3C2 P08235 1/20 0.30
ALDH3A1 P30838 2/20 0.30
AKR1C3 P42330 1/20 0.30
AKR1C2 P52895 1/20 0.30
VCAM1 P19320 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16610451 0.82 ALDH1A1 (0.42) KIF11ALDH1A1NPFFR1NPFFR2ALDH1A3
SCHEMBL6904240 0.81 ALDH1A1 (0.52) ALDH1A1ALDH1A3HSD17B10ALDH3A1VCAM1
SCHEMBL29579209 0.80 KIF11 (0.49) KIF11ALDH1A1GRIA1GRIA2GRIA3
SCHEMBL4331082 0.80 KIF11 (0.49) KIF11ALDH1A1GRIA1GRIA2GRIA3
SCHEMBL6515872 0.79 KIF11 (0.43) KIF11ALDH1A1NPFFR1NPFFR2KDR
SCHEMBL1205444 0.79 ALDH1A1 (0.39) KIF11ALDH1A1NPFFR1NPFFR2ALDH1A3
SCHEMBL3517749 0.79 ERN1 (0.40) KIF11ALDH1A1NPFFR1NPFFR2
SCHEMBL31611799 0.78 KIF11 (0.47) KIF11ALDH1A1NPFFR1NPFFR2HSD17B10
SCHEMBL9340504 0.77 KIF11 (0.35) KIF11ALDH1A1KDR
SCHEMBL19136810 0.75 ALDH1A1 (0.46) KIF11ALDH1A1ALDH1A3HSD17B10ALDH3A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0396987-B1 Nuclear fluorinated trifluoromethylbenzaldehydes BAYER AG (DE) 1994-06-15 EP claimed
EP-0396987-A2 Nuclear fluorinated trifluoromethylbenzaldehydes BAYER AG (DE) 1990-11-14 EP claimed
US-20230192661-A1 1, 4, 5, 6-TETRAHYDROPYRIMIDINE-2-AMINE DERIVATIVE UBE CORPORATION (JP) 2023-06-22 US disclosed
US-20230192661-A1 1, 4, 5, 6-TETRAHYDROPYRIMIDINE-2-AMINE DERIVATIVE UBE CORPORATION (JP) 2023-06-22 US disclosed
WO-2023085396-A1 PHARMACEUTICAL COMPOSITION FOR PROVIDING TREATMENT FOR OR PREVENTING ALPORT SYNDROME UBE株式会社 2023-05-19 WO disclosed
WO-2021230325-A1 1, 4, 5, 6-TETRAHYDROPYRIMIDINE-2-AMINE DERIVATIVE 宇部興産株式会社 2021-11-18 WO disclosed
EP-0396987-B1 Nuclear fluorinated trifluoromethylbenzaldehydes BAYER AG (DE) 1994-06-15 EP disclosed
US-5041683-A Nuclear-fluorinated trifluoromethylbenzaldehydes BAYER AKTIENGESELLSCHAFT (DE) 1991-08-20 US disclosed
EP-0396987-A2 Nuclear fluorinated trifluoromethylbenzaldehydes BAYER AG (DE) 1990-11-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192661-A1 1, 4, 5, 6-TETRAHYDROPYRIMIDINE-2-AMINE DERIVATIVE DHFR, DPYD, CYP2D6 KIF11 1926/4885ALDH1A1 208/4885NPFFR1 512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.